These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21622936)

  • 21. Activation of humoral immunity and eosinophils in neuromyelitis optica.
    Correale J; Fiol M
    Neurology; 2004 Dec; 63(12):2363-70. PubMed ID: 15623701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigation of B-cell activating factor in serum and cerebrospinal fluid of patients with neuromyelitis optical].
    Yang F; Huang D; Wu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):380-3. PubMed ID: 25818784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission.
    Wang S; Yang T; Wan J; Zhang Y; Fan Y
    Brain Behav; 2017 Apr; 7(4):e00648. PubMed ID: 28413701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis.
    Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG
    Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
    Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
    Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
    Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K
    Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
    Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
    Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica.
    Liu C; Xu Y; Cui L; Wang J; Peng B; Zhong L; Chen X
    J Clin Neurosci; 2013 Feb; 20(2):278-80. PubMed ID: 23164828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectral-domain optical coherence tomography of retinal nerve fiber layer thickness in NMO patients.
    Lange AP; Sadjadi R; Zhu F; Alkabie S; Costello F; Traboulsee AL
    J Neuroophthalmol; 2013 Sep; 33(3):213-9. PubMed ID: 23863782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
    Chitnis T; Ness J; Krupp L; Waubant E; Hunt T; Olsen CS; Rodriguez M; Lotze T; Gorman M; Benson L; Belman A; Weinstock-Guttman B; Aaen G; Graves J; Patterson M; Rose JW; Casper TC
    Neurology; 2016 Jan; 86(3):245-52. PubMed ID: 26683648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased soluble C5b-9 in CSF of neuromyelitis optica.
    Wang H; Wang K; Wang C; Qiu W; Lu Z; Hu X
    Scand J Immunol; 2014 Feb; 79(2):127-30. PubMed ID: 24313854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.
    Uchida T; Mori M; Uzawa A; Masuda H; Muto M; Ohtani R; Kuwabara S
    Mult Scler; 2017 Jul; 23(8):1072-1084. PubMed ID: 27682231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis.
    Wang L; Hu W; Wang J; Qian W; Xiao H
    Mult Scler Relat Disord; 2016 Sep; 9():17-22. PubMed ID: 27645338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.
    Uzawa A; Mori M; Masuda S; Muto M; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):517-22. PubMed ID: 23255728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
    Wang KC; Lee CL; Chen SY; Chen JC; Yang CW; Chen SJ; Tsai CP
    J Interferon Cytokine Res; 2013 Feb; 33(2):58-64. PubMed ID: 23398365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
    Papais-Alvarenga RM; Vasconcelos CC; Alves-Leon SV; Batista E; Santos CM; Camargo SM; Godoy M; Lacativa MC; Lorenti M; Damasceno B; Damasceno A; Brum D; Barreira AA; Guimarães Rocha MS; Alvarenga H; Tilbery CP
    Mult Scler; 2014 Mar; 20(3):374-81. PubMed ID: 23970504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
    Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
    J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.